Pipeline

Selvita is actively engaged in the discovery and development of breakthrough medicines primarily in the area of oncology.
Selvita develops its own innovative small molecule drugs, which originate from research at Polish universities and later commercializes them with partners from the pharmaceutical industry.

Our current program portfolio :